Marco Napoli
Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation
Napoli, Marco; Li, Xiaobo; Ackerman, Hayley D.; Deshpande, Avani A.; Barannikov, Ivan; Pisegna, Marlese A.; Bedrosian, Isabelle; Mitsch, Jürgen; Quinlan, Philip; Thompson, Alastair; Rajapakshe, Kimal; Coarfa, Cristian; Gunaratne, Preethi H.; Marchion, Douglas C.; Magliocco, Anthony M.; Tsai, Kenneth Y.; Flores, Elsa R.
Authors
Xiaobo Li
Hayley D. Ackerman
Avani A. Deshpande
Ivan Barannikov
Marlese A. Pisegna
Isabelle Bedrosian
Jürgen Mitsch
Philip Quinlan
Alastair Thompson
Kimal Rajapakshe
Cristian Coarfa
Preethi H. Gunaratne
Douglas C. Marchion
Anthony M. Magliocco
Kenneth Y. Tsai
Elsa R. Flores
Abstract
The most frequent genetic alterations across multiple human cancers are mutations in TP53 and the activation of the PI3K/AKT pathway, two events crucial for cancer progression. Mutations in TP53 lead to the inhibition of the tumour and metastasis suppressor TAp63, a p53 family member. By performing a mouse-human cross species analysis between the TAp63 metastatic mammary adenocarcinoma mouse model and models of human breast cancer progression, we identified two TAp63-regulated oncogenic lncRNAs, TROLL-2 and TROLL-3. Further, using a pan-cancer analysis of human cancers and multiple mouse models of tumour progression, we revealed that these two lncRNAs induce the activation of AKT to promote cancer progression by regulating the nuclear to cytoplasmic translocation of their effector, WDR26, via the shuttling protein NOLC1. Our data provide preclinical rationale for the implementation of these lncRNAs and WDR26 as therapeutic targets for the treatment of human tumours dependent upon mutant TP53 and/or the PI3K/AKT pathway.
Citation
Napoli, M., Li, X., Ackerman, H. D., Deshpande, A. A., Barannikov, I., Pisegna, M. A., Bedrosian, I., Mitsch, J., Quinlan, P., Thompson, A., Rajapakshe, K., Coarfa, C., Gunaratne, P. H., Marchion, D. C., Magliocco, A. M., Tsai, K. Y., & Flores, E. R. (2020). Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation. Nature Communications, 11, Article 5156. https://doi.org/10.1038/s41467-020-18973-w
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 24, 2020 |
Online Publication Date | Oct 14, 2020 |
Publication Date | 2020-12 |
Deposit Date | Jun 17, 2024 |
Publicly Available Date | Jun 20, 2024 |
Journal | Nature Communications |
Electronic ISSN | 2041-1723 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Article Number | 5156 |
DOI | https://doi.org/10.1038/s41467-020-18973-w |
Keywords | General Biochemistry, Genetics and Molecular Biology; General Physics and Astronomy; General Chemistry |
Public URL | https://nottingham-repository.worktribe.com/output/4974453 |
Publisher URL | https://www.nature.com/articles/s41467-020-18973-w |
Files
Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation
(2.4 Mb)
PDF
You might also like
A SARS-CoV-2 minimum data standard to support national serology reporting
(2024)
Journal Article
Lessons learned from the COVID-19 pandemic about sample access for research in the UK
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search